Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

NYSE:MET

Metlife (MET)

88.57
+0.91 (1.04%)
as of Jun 16, 2026, 1:32:16 pm Market Open.
36 watching
0
Investor Insights
star iconJun 15, 2026, 12:00 am

This summary was created by AI, based on 1 opinions in the last 12 months.

MetLife Inc. (MET-N) has recently achieved a significant milestone by reaching a new 52-week high, signaling a strong performance in the market. Analysts characterize the company as solid, conservative, and defensive, suggesting that it has made prudent investments that align well with current market conditions. This reputation for stability is particularly appealing in times of market volatility, making MetLife an attractive option for risk-averse investors. With a focus on the right sectors, the company is positioned to endure economic fluctuations while potentially delivering steady returns to its shareholders. Overall, the positive sentiment surrounding MetLife reflects confidence in its strategic approach and long-term outlook.

consensus icon
Consensus
Positive
valuation icon
Valuation
Fair Value
review icon
Similar
AXA,AXA
PAST TOP PICK
(A Top Pick Mar 29/18, Up 3%) Slow or flar growth this and next year, but they are buying back stock. He sees 9% EPS growth this year. Their US retirement portfolio has been doing well. It's cheap at 8x PE and paying almost a 4% dividend. It's been stagnant for many years, but it has tailwinds of lower taxes and volume growth. They're growing in Asia and Europe.
DON'T BUY
Metlife vs. Prudential vs US banks Both are high quality and international. Strong. He doesn't love lifecos now, because there's a lot going on in health, such as the prevalance of diabetes. He wants to see higher interest rates which can benefit lifecos. As for banks, he'd stay away. The rates and yield curve have flattened. Met are doing the right thing, like a nice dividend and a big share buybacks. It isn't expensive and doing 10% earnings growth, but there are greener pastures elsewhere.
COMMENT
Insurance companies are trading below their lower benchmarks -- making him think there are issues with their balance sheets especially in a deflationary recession environment. This could lead to lower short term rates, which could impair their earnings. He would be cautious going forward for all insurance companies.
DON'T BUY
SLF-T vs. MET-N. He prefers Sunlife (SLF-T). It is higher quality and more defensive. Also they are down with the sector. There is more competition in the US vs. Canada.
PAST TOP PICK

(A Top Pick July 11, 2017. Down 7%). This has gone down even as interest rates have come up. He is holding with it, with a very small position. Life insurers are not participating in the financials rally as much as he expected. His model price shows a 47% upside, but the market appears to dislike some aspect of MetLife’s balance sheet and he is not sure what that is. Because he is not sure what is wrong, he would not buy it.

COMMENT

One of the biggest life insurance companies. Spawned off the individual insurance part in a company called Brighthouse earlier this year. MetLife has been hurt lately by some controversy. In the long run still likes the outlook for both Brighthouse and Metlife, and rising interests rate do help insurance companies a lot.

PAST TOP PICK

(A Top Pick July 11/17 Down 2%) All the insurers are being helped by rising interest rates, yet the stock price has not increased. He is disappointed by the performance, but will continue to stick with it. He has a model price about 30% higher. Yield 3.5%.

PAST TOP PICK

(A Top Pick May 1/17, Up 5%) It spun out Bright House. He continues to own both. They had to take a hit on benefits that people were not getting and should have.

DON'T BUY

This is a diversified insurance company with a bias to life. It is in a good capital situation. The technical chart is too boom and bust, which he can’t explain. Insurance broadly has generally under-performed and he thinks you are taking more risk than the reward you are getting. He would prefer straight financial stocks instead.

TOP PICK

A sleepy little story. It is really cheap. He likes it for strong buybacks, dividend growth and upping their return on equity. 11% forecast earnings growth. (Analysts’ target: $55.00).

PAST TOP PICK

(A Top Pick Jan 13/17. Up 15%.) Still likes this. It’s trading at about 1X Price to Book, which is cheap in the financial world. Pays about a 3% dividend, which is expected to grow 6%-7% over the next several years. Right now, the 10-year treasury is above 260 and rising interest rates will help companies like this. They have very strong international operations. 3% dividend yield.

PAST TOP PICK

(A Top Pick May 8/17. Up 15%.) Changes to the US are positive in one sense, but there are problems in the insurance industry in another. Interest rates are going up, which should help. He would probably hang in, with the admonition that if something better came along, he might jump.

COMMENT

Versus American banks?He likes US banks versus insurance companies. Banks are in a much better position to deliver earnings growth, versus some of the insurers. Insurers, both in Canada and US, do a little better when interest rates go up. Their liabilities go down and they also get a better return on assets. There is better risk/reward on the banks.

COMMENT

He likes the insurance companies in the US. This recently did a spinoff of their smaller financial division. It has recently spiked over the last couple of months. Trading at 11X earnings with a decent growth rate. Insurance companies, particularly in the US, are going to move along with what is going to happen with interest rates. He likes insurance companies, but wouldn’t ignore large US banks. Dividend yield of 3%.

PAST TOP PICK

(A Top Pick Nov 8/16. Up 12%.) One of the biggest financial companies in the US. In late July, they spun out their consumer division, which he took advantage of. He still likes the outlook for this company.

Showing 16 to 30 of 112 entries